Apparently, both markets are clueless. Hopefully, when positive Phase I results are presented, we'll see a much more significant uptick.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025